A genome scan for positive selection in thoroughbred horses

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Gu, Jingjing ^a   Orr, Nick ^a,b   Park, Stephen D ^a   Katz, Lisa M ^a   Sulimova, Galina ^c   MacHugh, David E ^a   Hill, Emmeline W ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c VAVILOV INSTITUTE OF GENERAL GENETICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; ALPHA ACTININ 1; ALPHA ACTININ 2; ALPHA ACTININ 3; ALPHA3 INTEGRIN; CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE; COLLAGEN TYPE 2; COLLAGEN TYPE 4; INSULIN RECEPTOR; LAMININ; LONG CHAIN FATTY ACID COENZYME A LIGASE; MITOCHONDRIAL FISSION REGULATOR 1; MUSCLE PROTEIN; PYRUVATE DEHYDROGENASE; REGULATOR PROTEIN; SARCOGLYCAN; TENASCIN; UNCLASSIFIED DRUG; MICROSATELLITE DNA;

ARTICLE; BREEDING; EXERCISE; FATTY ACID OXIDATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENETIC SELECTION; GENOME ANALYSIS; HETEROZYGOSITY; HORSE; INSULIN SENSITIVITY; LIPID TRANSPORT; MICROSATELLITE MARKER; MUSCLE STRENGTH; NONHUMAN; PHENOTYPE; POPULATION GENETICS; SIGNAL TRANSDUCTION; SPECIES DIVERSITY; ALLELE; ANIMAL; ANOXIA; CHROMOSOME; GENETIC VARIABILITY; GENETICS; GENOME; GENOMICS; HETEROZYGOTE; METABOLISM; MUSCLE; ULTRASTRUCTURE;

ANIMALIA; EQUIDAE;

ALLELES; ANIMALS; ANOXIA; CHROMOSOMES; GENETIC VARIATION; GENOME; GENOMICS; HETEROZYGOTE; HORSES; MICROSATELLITE REPEATS; MUSCLES; PHENOTYPE; SELECTION (GENETICS);

EID: 66849126008     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005767     Document Type: Article

References (137)

1. Levine M (1999) The origins of horse husbandry on the Eurasian Steppe. In: Levine M, Rassamakin Y, Kislenko A, Tatarintseva N, eds. Late prehistoric exploitation of the Eurasian steppe. Cambridge: McDonald Institute for Archaeological Research. pp 5-58.
2. Jones JH, Lindstedt SL (1993) Limits to maximal performance. Annu Rev Physiol 55: 547-569.
3. Jones JH, Longworth KE, Lindholm A, Conley KE, Karas RH, et al. (1989) Oxygen transport during exercise in large mammals. I. Adaptive variation in oxygen demand. J Appl Physiol 67: 862-870.
4. Young LE, Marlin DJ, Deaton C, Brown-Feltner H, Roberts CA, et al. (2002) Heart size estimated by echocardiography correlates with maximal oxygen uptake. Equine Vet J Suppl: 467-471.
5. Constantinopol M, Jones JH, Weibel ER, Taylor CR, Lindholm A, et al. (1989) Oxygen transport during exercise in large mammals. II. Oxygen uptake by the pulmonary gas exchanger. J Appl Physiol 67: 871-878.
6. Essen-Gustavsson B, Lindholm A (1985) Muscle fibre characteristics of active and inactive standardbred horses. Equine Vet J 17: 434-438.
7. Hinchcliff KW, Geor RJ (2008) The horse as an athlete: a physiological overview. Equine exercise physiology: the science of exercise in the athletic horse. Edinburgh; New York: Saunders/Elsevier. pp ix, 463.
8. Hyyppa S, Rasanen LA, Poso AR (1997) Resynthesis of glycogen in skeletal muscle from standardbred trotters after repeated bouts of exercise. Am J Vet Res 58: 162-166.
9. Poso AR, Essengustavsson B, Persson SGB (1993) Metabolic response to standardized exercise test in standard-bred trotters with red-cell hypervolemia. Equine Vet J 25: 527-531.
10. Wagner PD (1995) Determinants of V-O2max: Man vs horse. J Equine Vet Sci 15: 398-404.
11. Katz LM, Bayly WM, Hines MT, Sides RH (2005) Ventilatory responses of ponies and horses to exercise. Equine Comp Exercise Phys 2: 229-240.
12. Dempsey JA, Wagner PD (1999) Exercise-induced arterial hypoxemia. J Appl Physiol 87: 1997-2006.
13. Willett P (1975) An introduction to the thoroughbred. London: Paul.
14. Cunningham EP, Dooley JJ, Splan RK, Bradley DG (2001) Microsatellite diversity, pedigree relatedness and the contributions of founder lineages to thoroughbred horses. Anim Genet 32: 360-364.
15. Gaffney B, Cunningham EP (1988) Estimation of genetic trend in racing performance of thoroughbred horses. Nature 332: 722-724.
16. Mota MD, Abrahao AR, Oliveira HN (2005) Genetic and environmental parameters for racing time at different distances in Brazilian Thoroughbreds. J Anim Breed Genet 122: 393-399.
17. Pollinger JP, Bustamante CD, Fledel-Alon A, Schmutz S, Gray MM, et al. (2005) Selective sweep mapping of genes with large phenotypic effects. Genome Res 15: 1809-1819.
18. Schlotterer C (2003) Hitchhiking mapping-functional genomics from the population genetics perspective. Trends Genet 19: 32-38.
19. Kayser M, Brauer S, Stoneking M (2003) A genome scan to detect candidate regions influenced by local natural selection in human populations. Mol Biol Evol 20: 893-900.
20. Akey JM, Zhang G, Zhang K, Jin L, Shriver MD (2002) Interrogating a high-density SNP map for signatures of natural selection. Genome Res 12: 1805-1814.
21. Kauer MO, Dieringer D, Schlotterer C (2003) A microsatellite variability screen for positive selection associated with the "out of Africa" habitat expansion of Drosophila melanogaster. Genetics 165: 1137-1148.
22. Payseur BA, Cutter AD, Nachman MW (2002) Searching for evidence of positive selection in the human genome using patterns of microsatellite variability. Mol Biol Evol 19: 1143-1153.
23. Harr B, Kauer M, Schlotterer C (2002) Hitchhiking mapping: a population-based fine-mapping strategy for adaptive mutations in Drosophila melanogaster. Proc Natl Acad Sci U S A 99: 12949-12954.
24. Mattiangeli V, Ryan AW, McManus R, Bradley DG (2006) A genome-wide approach to identify genetic loci with a signature of natural selection in the Irish population. Genome Biol 7: R74.
25. Watterson GA (1978) An Analysis of Multi-Allelic Data. Genetics 88: 171-179.
26. Thornton KR, Jensen JD, Becquet C, Andolfatto P (2007) Progress and prospects in mapping recent selection in the genome. Heredity 98: 340-348.
27. Myles S, Tang K, Somel M, Green RE, Kelso J, et al. (2008) Identification and analysis of genomic regions with large between-population differentiation in humans. Ann Hum Genet 72: 99-110.
28. Myles S, Davison D, Barrett J, Stoneking M, Timpson N (2008) Worldwide population differentiation at disease-associated SNPs. BMC Med Genomics 1: 22.
29. Beaumont MA, Balding DJ (2004) Identifying adaptive genetic divergence among populations from genome scans. Mol Ecol 13: 969-980.
30. Parker HG, Kim LV, Sutter NB, Carlson S, Lorentzen TD, et al. (2004) Genetic structure of the purebred domestic dog. Science 304: 1160-1164.
31. Mickelson J, McCue M, Bannasch D, Penedo C, Bailey E, et al. (2009) Evaluation of the EquineSNP50 BeadChips; San Diego, USA.
32. The Gene Ontology Consortium (2008) The Gene Ontology project in 2008. Nucleic Acids Res 36: D440-444.
33. Zuccarello D, Ferlin A, Cazzadore C, Pepe A, Garolla A, et al. (2008) Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia. Hum Reprod 23: 1957-1962.
34. O'Brien RM, Granner DK (1996) Regulation of gene expression by insulin. Physiol Rev 76: 1109-1161.
35. Roques M, Vidal H (1999) A phosphatidylinositol 3-Kinase/p70 ribosomal S6 protein kinase pathway is required for the regulation by insulin of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase gene expression in human muscle cells. J Biol Chem 274: 34005-34010.
36. Shepherd PR, Withers DJ, Siddle K (1998) Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 333(Pt 3): 471-490.
37. Hayashi K, Saga H, Chimori Y, Kimura K, Yamanaka Y, et al. (1998) Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase. J Biol Chem 273: 28860-28867.
38. Andreelli F, Laville M, Ducluzeau PH, Vega N, Vallier P, et al. (1999) Defective regulation of phosphatidylinositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients. Diabetologia 42: 358-364.
39. Ducluzeau PH, Perretti N, Laville M, Andreelli F, Vega N, et al. (2001) Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes. Diabetes 50: 1134-1142.
40. Tsuchida H, Bjornholm M, Fernstrom M, Galuska D, Johansson P, et al. (2002) Gene expression of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in skeletal muscle from type 2 diabetic subjects. Pflugers Arch 445: 25-31.
41. Lebrun P, Van Obberghen E (2008) SOCS proteins causing trouble in insulin action. Acta Physiol (Oxf) 192: 29-36.
42. Holmkvist J, Tojjar D, Almgren P, Lyssenko V, Lindgren CM, et al. (2007) Polymorphisms in the gene encoding the voltage-dependent Ca(2+) channel Ca (V)2.3 (CACNA1E) are associated with type 2 diabetes and impaired insulin secretion. Diabetologia 50: 2467-2475.
43. Tonachini L, Monticone M, Puri C, Tacchetti C, Pinton P, et al. (2004) Chondrocyte protein with a poly-proline region (CHPPR) is a novel mitochondrial protein and promotes mitochondrial fission. J Cell Physiol 201: 470-482.
44. Monticone M, Tonachini L, Tavella S, Degan P, Biticchi R, et al. (2007) Impaired expression of genes coding for reactive oxygen species scavenging enzymes in testes of Mtfr1/Chppr-deficient mice. Reproduction 134: 483-492.
45. Kardon T, Noel G, Vertommen D, Schaftingen EV (2006) Identification of the gene encoding hydroxyacid-oxoacid transhydrogenase, an enzyme that metabolizes 4-hydroxybutyrate. FEBS Lett 580: 2347-2350.
46. Takahara J, Yunoki S, Yakushiji W, Yamauchi J, Yamane Y (1977) Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J Clin Endocrinol Metab 44: 1014-1017.
47. Van Cauter E, Plat L, Scharf MB, Leproult R, Cespedes S, et al. (1997) Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men. J Clin Invest 100: 745-753.
48. Williams H, Taylor R, Roberts M (1998) Gamma-hydroxybutyrate (GHB): a new drug of misuse. Ir Med J 91: 56-57.
49. Galloway GP, Frederick SL, Staggers FE Jr, Gonzales M, Stalcup SA, et al. (1997) Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 92: 89-96.
50. Vlahos CJ, Matter WF, Hui KY, Brown RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248.
51. Kim JY, Tillison KS, Zhou S, Lee JH, Smas CM (2007) Differentiation-dependent expression of Adhfe1 in adipogenesis. Arch Biochem Biophys 464: 100-111.
52. Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, et al. (2008) New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454: 1000-1004.
53. Seale P, Bjork B, Yang W, Kajimura S, Chin S, et al. (2008) PRDM16 controls a brown fat/skeletal muscle switch. Nature 454: 961-967.
54. Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, et al. (2006) The human obesity gene map: the 2005 update. Obesity (Silver Spring) 14: 529-644.
55. Kawabata M, Imamura T, Miyazono K (1998) Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9: 49-61.
56. Canalis E, Economides AN, Gazzerro E (2003) Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24: 218-235.
57. Voight BF, Kudaravalli S, Wen X, Pritchard JK (2006) A map of recent positive selection in the human genome. PLoS Biol 4: e72.
58. Hansen JB, Jorgensen C, Petersen RK, Hallenborg P, De Matteis R, et al. (2004) Retinoblastoma protein functions as a molecular switch determining white versus brown adipocyte differentiation. Proc Natl Acad Sci U S A 101: 4112-4117.
59. Wende AR, Huss JM, Schaeffer PJ, Giguere V, Kelly DP (2005) PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism. Mol Cell Biol 25: 10684-10694.
60. Scarpulla RC (2008) Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 88: 611-638.
61. Bottcher Y, Tonjes A, Enigk B, Scholz GH, Bluher M, et al. (2007) A SNP haplotype of the forkhead transcription factor FOXO1A gene may have a protective effect against type 2 diabetes in German Caucasians. Diabetes Metab 33: 277-283.
62. Allen DL, Unterman TG (2007) Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am J Physiol Cell Physiol 292: C188-199.
63. Zoll J, Ponsot E, Dufour S, Doutreleau S, Ventura-Clapier R, et al. (2006) Exercise training in normobaric hypoxia in endurance runners. III. Muscular adjustments of selected gene transcripts. J Appl Physiol 100: 1258-1266.
64. Semenza GL (1998) Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 8: 588-594.
65. Prior SJ, Hagberg JM, Phares DA, Brown MD, Fairfull L, et al. (2003) Sequence variation in hypoxia-inducible factor 1alpha (HIF1A): association with maximal oxygen consumption. Physiol Genomics 15: 20-26.
66. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613.
67. Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, et al. (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93: 1074-1081.
68. Benton CR, Nickerson JG, Lally J, Han XX, Holloway GP, et al. (2008) Modest PGC-1alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria. J Biol Chem 283: 4228-4240.
69. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, et al. (2007) HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129: 111-122.
70. Burgomaster KA, Cermak NM, Phillips SM, Benton CR, Bonen A, et al. (2007) Divergent response of metabolite transport proteins in human skeletal muscle after sprint interval training and detraining. Am J Physiol Regul Integr Comp Physiol 292: R1970-1976.
71. Fluck M (2006) Functional, structural and molecular plasticity of mammalian skeletal muscle in response to exercise stimuli. J Exp Biol 209: 2239-2248.
72. Sahlin K, Harris RC (2008) Control of lipid oxidation during exercise: role of energy state and mitochondrial factors. Acta Physiol (Oxf).
73. Gunn HM (1987) Muscle, bone and fat proportions and muscle distribution of thoroughbreds and other horses. In: Gillespie JR, Robinson NE, eds. Equine exercise physiology 2: proceedings of the Second International Conference on Equine Exercise Physiology, San Diego, California, August 7-11, 1986. Davis, Calif.: ICEEP Publications. pp 253-264.
74. Kearns CF, McKeever KH, Abe T (2002) Overview of horse body composition and muscle architecture: implications for performance. Vet J 164: 224-234.
75. Tobacman LS (1996) Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol 58: 447-481.
76. Gordon AM, Homsher E, Regnier M (2000) Regulation of contraction in striated muscle. Physiol Rev 80: 853-924.
77. Clarke NF, Ilkovski B, Cooper S, Valova VA, Robinson PJ, et al. (2007) The pathogenesis of ACTA1-related congenital fiber type disproportion. Ann Neurol 61: 552-561.
78. Ochala J (2008) Thin filament proteins mutations associated with skeletal myopathies: Defective regulation of muscle contraction. J Mol Med 86: 1197-1204.
79. Shibasaki F, Fukami K, Fukui Y, Takenawa T (1994) Phosphatidylinositol 3-kinase binds to alpha-actinin through the p85 subunit. Biochem J 302(Pt 2): 551-557.
80. MacArthur DG, Seto JT, Chan S, Quinlan KG, Raftery JM, et al. (2008) An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Hum Mol Genet 17: 1076-1086.
81. Chan S, Seto JT, MacArthur DG, Yang N, North KN, et al. (2008) A gene for speed: contractile properties of isolated whole EDL muscle from an alpha-actinin-3 knockout mouse. Am J Physiol Cell Physiol 295: C897-904.
82. Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, et al. (2003) ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 73: 627-631.
83. MacArthur DG, Seto JT, Raftery JM, Quinlan KG, Huttley GA, et al. (2007) Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans. Nat Genet 39: 1261-1265.
84. Mills M, Yang N, Weinberger R, Vander Woude DL, Beggs AH, et al. (2001) Differential expression of the actin-binding proteins, alpha-actinin-2 and -3, in different species: implications for the evolution of functional redundancy. Hum Mol Genet 10: 1335-1346.
85. Marco S, Carrascosa JL, Valpuesta JM (1994) Reversible interaction of beta-actin along the channel of the TCP-1 cytoplasmic chaperonin. Biophys J 67: 364-368.
86. Liou AK, Willison KR (1997) Elucidation of the subunit orientation in CCT (chaperonin containing TCP1) from the subunit composition of CCT microcomplexes. EMBO J 16: 4311-4316.
87. Llorca O, Martin-Benito J, Gomez-Puertas P, Ritco-Vonsovici M, Willison KR, et al. (2001) Analysis of the interaction between the eukaryotic chaperonin CCT and its substrates actin and tubulin. J Struct Biol 135: 205-218.
88. Ozawa E, Mizuno Y, Hagiwara Y, Sasaoka T, Yoshida M (2005) Molecular and cell biology of the sarcoglycan complex. Muscle Nerve 32: 563-576.
89. Pardo JV, Siliciano JD, Craig SW (1983) A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements ("costameres") mark sites of attachment between myofibrils and sarcolemma. Proc Natl Acad Sci U S A 80: 1008-1012.
90. Mizuno Y, Yoshida M, Nonaka I, Hirai S, Ozawa E (1994) Expression of utrophin (dystrophin-related protein) and dystrophin-associated glycoproteins in muscles from patients with Duchenne muscular dystrophy. Muscle Nerve 17: 206-216.
91. Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D, et al. (2001) Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 29: 66-69.
92. Grabowski M, Zimprich A, Lorenz-Depiereux B, Kalscheuer V, Asmus F, et al. (2003) The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Eur J Hum Genet 11: 138-144.
93. Muller B, Hedrich K, Kock N, Dragasevic N, Svetel M, et al. (2002) Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 71: 1303-1311.
94. Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, et al. (1998) Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol 142: 1461-1471.
95. Samarel AM (2005) Costameres, focal adhesions, and cardiomyocyte mechanotransduction. Am J Physiol Heart Circ Physiol 289: H2291-2301.
96. Fluck M, Mund SI, Schittny JC, Klossner S, Durieux AC, et al. (2008) Mechano-regulated tenascin-C orchestrates muscle repair. Proc Natl Acad Sci U S A 105: 13662-13667.
97. Durieux AC, Desplanches D, Freyssenet D, Fluck M (2007) Mechanotransduction in striated muscle via focal adhesion kinase. Biochem Soc Trans 35: 1312-1313.
98. World Health Organization (2000) Obesity: preventing and managing the global epidemic (technical report series 894). Geneva: World Health Organization.
99. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, et al. (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340: 925-929.
100. Kelley DE, Mandarino LJ (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49: 677-683.
101. Booth FW, Chakravarthy MV, Gordon SE, Spangenburg EE (2002) Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. J Appl Physiol 93: 3-30.
102. Handschin C, Spiegelman BM (2008) The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 454: 463-469.
103. Kronfeld DS, Treiber KH, Hess TM, Boston RC (2005) Insulin resistance in the horse: Definition, detection, and dietetics. J Anim Sci 83: E22-31.
104. Johnson PJ (2002) The equine metabolic syndrome peripheral Cushing's syndrome. Vet Clin North Am Equine Pract 18: 271-293.
105. Frank N (2006) Insulin resistance in horses. AAEP Proceedings 52: 51-54.
106. Treiber KH, Boston RC, Kronfeld DS, Staniar WB, Harris PA (2005) Insulin resistance and compensation in Thoroughbred weanlings adapted to high-glycemic meals. J Anim Sci 83: 2357-2364.
107. Hoffman RM, Boston RC, Stefanovski D, Kronfeld DS, Harris PA (2003) Obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings. J Anim Sci 81: 2333-2342.
108. Houston ME (2006) Biochemistry primer for exercise science. Champaign, IL: Human Kinetics. pp xi, 267.
109. Geor RJ, Hinchcliff KW, Sams RA (2000) beta-adrenergic blockade augments glucose utilization in horses during graded exercise. J Appl Physiol 89: 1086-1098.
110. Geor RJ, McCutcheon LJ, Hinchcliff KW, Sams RA (2002) Training-induced alterations in glucose metabolism during moderate-intensity exercise. Equine Vet J Suppl: 22-28.
111. Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806.
112. Kronfeld DS, Custalow SE, Ferrante PL, Taylor LE, Moll HD, et al. (2000) Determination of the lactate breakpoint during incremental exercise in horses adapted to dietary corn oil. Am J Vet Res 61: 144-151.
113. Oldham SL, Potter GD, Evans JW, Smith SB, Taylor TS, et al. (1990) Storage and mobilization of muscle glycogen in exercising horses fed a fat-supplemented diet. J Equine Vet Sci 10: 353-359.
114. Eaton MD, Hodgson DR, Evans DL (1995) Effect of diet containing supplementary fat on the effectiveness for high intensity exercise. Equine Vet J Suppl 18: 353-356.
115. Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84: 277-359.
116. Nedergaard J, Bengtsson T, Cannon B (2007) Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293: E444-452.
117. Guerra C, Koza RA, Yamashita H, Walsh K, Kozak LP (1998) Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest 102: 412-420.
118. Pilegaard H, Neufer PD (2004) Transcriptional regulation of pyruvate dehydrogenase kinase 4 in skeletal muscle during and after exercise. Proc Nutr Soc 63: 221-226.
119. Guilherme A, Virbasius JV, Puri V, Czech MP (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9: 367-377.
120. Gunn HM (1983) Morphological attributes associated with speed of running in horses. In: Snow DH, Persson SGB, Rose RJ, eds. Proceedings of the First International Conference on Equine Exercise Physiology. Cambridge: Burlington Press. pp 271-274.
121. Bell RH Jr, Hye RJ (1983) Animal models of diabetes mellitus: physiology and pathology. J Surg Res 35: 433-460.
122. Bray GA, York DA (1979) Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 59: 719-809.
123. Weatherby and Sons (1791) An introduction to a general stud book. London: Weatherby and Sons.
124. Sambrook J, Russell DW (2001) Molecular cloning : a laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press.
125. Tozaki T, Hirota K, Hasegawa T, Ishida N, Tobe T (2007) Whole-genome linkage disequilibrium screening for complex traits in horses. Mol Genet Genomics 277: 663-672.
126. Swinburne JE, Boursnell M, Hill G, Pettitt L, Allen T, et al. (2006) Single linkage group per chromosome genetic linkage map for the horse, based on two three-generation, full-sibling, crossbred horse reference families. Genomics 87: 1-29.
127. Penedo MC, Millon LV, Bernoco D, Bailey E, Binns M, et al. (2005) International Equine Gene Mapping Workshop Report: a comprehensive linkage map constructed with data from new markers and by merging four mapping resources. Cytogenet Genome Res 111: 5-15.
128. Rotmistrovsky K, Jang W, Schuler GD (2004) A web server for performing electronic PCR. Nucleic Acids Res 32: W108-112.
129. Smith JM, Haigh J (1974) The hitch-hiking effect of a favourable gene. Genet Res 23: 23-35.
130. Kaplan NL, Hudson RR, Langley CH (1989) The "hitchhiking effect" revisited. Genetics 123: 887-899.
131. Weir BS, Cockerham CC (1984) Estimating F-statistics for the analysis of population structure. Evolution 38: 1358-1370.
132. Weir BS, Hill WG (2002) Estimating F-statistics. Annu Rev Genet 36: 721-750.
133. Goudet J (1995) FSTAT (version 1.2): a computer program to calculate F-statistics. J Hered 86: 485-486.
134. Ewens WJ (1972) The sampling theory of selectively neutral alleles. Theor Popul Biol 3: 87-112.
135. Cornuet JM, Luikart G (1996) Description and power analysis of two tests for detecting recent population bottlenecks from allele frequency data. Genetics 144: 2001-2014.
136. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
137. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.